Bal Pharma Limited (BOM:524824)
India · Delayed Price · Currency is INR 75.54
+1.22 (1.64%)
At close: Feb 13, 2026
Bal Pharma Market Cap
Bal Pharma has a market cap or net worth of 1.2 billion as of February 13, 2026. Its market cap has decreased by -31.90% in one year.
Market Cap
1.20B
Enterprise Value
2.66B
Revenue
3.11B
Ranking
n/a
PE Ratio
14.94
Stock Price
75.54
Market Cap Chart
Since December 20, 2004, Bal Pharma's market cap has increased from 559.95M to 1.20B, an increase of 114.78%. That is a compound annual growth rate of 3.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.20B | 3.13% |
| Dec 31, 2025 | 1.17B | -39.96% |
| Dec 31, 2024 | 1.94B | 23.18% |
| Dec 29, 2023 | 1.58B | 10.20% |
| Dec 30, 2022 | 1.43B | -8.67% |
| Dec 31, 2021 | 1.57B | 96.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Astonea Labs | 1.65B |
| Bilcare | 1.60B |
| Parnax Lab | 1.40B |
| Pharmaids Pharmaceuticals | 1.38B |
| Sotac Pharmaceuticals | 1.31B |
| Lactose (India) | 1.29B |
| Concord Drugs | 1.06B |
| Mercury Laboratories | 966.18M |